Multi-year renewed commitment expands assured subscription-based access to high-frequency, dawn-to-dusk imagery and AI-driven analytics HERNDON,…
LP-184 is a novel, synthetically-lethal, small molecule that has been developed using insights from Lantern’s…
1. Coders and Software Developers: AI’s speed and accuracy have the potential to automate coding…
Lugano, Switzerland, June, 12, 2023 – Helsinn Group (“Helsinn”), a fully integrated global biopharma company…
Lugano, Switzerland, June, 12, 2023 – Helsinn Group (“Helsinn”), a fully integrated global biopharma company…
– Funding in place to meet next regulatory milestone BOSTON, MASSACHUSETTS, June 12, 2023 (GLOBE…
– Funding in place to meet next regulatory milestone BOSTON, MASSACHUSETTS, June 12, 2023 (GLOBE…
The Company expands technology for patients with obsessive-compulsive disorder MALVERN, Pa., June 12, 2023 (GLOBE…
The Company expands technology for patients with obsessive-compulsive disorder MALVERN, Pa., June 12, 2023 (GLOBE…
Company’s priority oncology clinical programs continue to advance toward key milestones Additional clinical trial site…
Company’s priority oncology clinical programs continue to advance toward key milestones Additional clinical trial site…
Webcast scheduled for Thursday, June 15 at 8:30am PT IRVINE, Calif., June 12, 2023 (GLOBE…
Webcast scheduled for Thursday, June 15 at 8:30am PT IRVINE, Calif., June 12, 2023 (GLOBE…
Dr. Corinne Le Goff will highlight the breakthrough potential of IMNN-001 for the treatment of…
Dr. Corinne Le Goff will highlight the breakthrough potential of IMNN-001 for the treatment of…
BASKING RIDGE, N.J., June 12, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
BASKING RIDGE, N.J., June 12, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
Fremont, C, June 12, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
Fremont, C, June 12, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
AGOURA HILLS, Calif., June 12, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…